A.M. Peny

Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma

Thierry Façon, J. Jenifer Florence Mary, Jean‐Luc Harousseau et al. · Journal of Clinical Oncology · 2006 · 195 citations

Medicine, Oncology, Pharmacotherapy +14

Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study.

Florence Joly, M. Henry‐Amar, Patrick Arveux et al. · Journal of Clinical Oncology · 1996 · 129 citations

Medicine, Oncology, Cancer Epidemiology +12

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.

B. Bui, B Chevallier, Christine Chevreau et al. · Journal of Clinical Oncology · 1995 · 76 citations

Medicine, Oncology, Pharmacology +13

High Grade Primary Breast Lymphoma: is it a Different Clinical Entity?

Christophe Fruchart, Yves Denoux, Jacques Chasle et al. · Breast Cancer Research and Treatment · 2005 · 39 citations

Medicine, Oncology, Pathology +6

Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.

Christian Gisselbrecht, J.M. Extra, JP Lotz et al. · PubMed · 1996 · 27 citations

Medicine, Oncology, Pharmacology +14